Keyphrases
Rheumatoid Arthritis
66%
Temporal Trends
66%
Population-based
66%
Danish Population
66%
Matched Cohort Study
66%
Relative Risk
41%
Health Registers
33%
RA Patients
33%
N-3 Polyunsaturated Fatty Acids
33%
COVID-19 Hospitalization
33%
Rheumatoid Arthritis Protocol
33%
Interrupted Time Series
33%
Upper Limb Joints
33%
Systemic Lupus Erythematosus
33%
Risk Difference
33%
5-year Mortality
33%
Excess Mortality
25%
Time-to-event Analysis
23%
COVID-19 Incidence
22%
National Cohort Study
16%
All-cause Mortality
16%
Pseudo-observations
16%
Mortality Risk
16%
Incident Cases
16%
Crude Risk
16%
Calendar Period
16%
Docosahexaenoic Acid
13%
Denmark
13%
Eicosapentaenoic Acid
13%
Severe COVID-19
11%
Age-adjusted
8%
Birth Timing
8%
Cumulative Incidence
8%
Incidence Rate
8%
Sex-specific Differences
8%
Disease Progression
8%
Risk-adjusted
8%
Disease Course
8%
10-year Mortality
8%
Comorbidity
8%
Administrative Health
8%
Young Patients
8%
Low Risk
8%
Disease Comorbidity
8%
Decreasing Trend
8%
Period Mortality
8%
Health Registries
8%
Potential Risk Factors
6%
Association Measures
6%
Rheumatoid Arthritis Diagnosis
6%
Medicine and Dentistry
Rheumatoid Arthritis
100%
Cohort Analysis
100%
Population
46%
Mortality
36%
Upper Limb
33%
Diet and Cancer
33%
Omega-3 Fatty Acid
33%
Cohort Effect
33%
Health Care
33%
Operation on Joint
33%
Systemic Lupus Erythematosus
33%
Attributable Risk
25%
Joint Replacement
22%
All Cause Mortality
19%
Childbirth
16%
Cumulative Incidence
16%
Disease Modifying Antirheumatic Drug
14%
Biological Product
14%
Docosahexaenoic Acid
9%
Icosapentaenoic Acid
9%
Comorbidity
6%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
69%
Prevalence
33%
Rheumatoid Arthritis
33%
Rheumatic Disease
33%
Systemic Lupus Erythematosus
33%
Glucocorticoid
11%
Infection
11%
Vasculitis
11%
Tumor Necrosis Factor Inhibitor
11%
Comorbidity
6%
Psoriatic Arthritis
5%
Adult Respiratory Distress Syndrome
5%
Connective Tissue Disease
5%
Spondylarthritis
5%
